15047131

Source:http://linkedlifedata.com/resource/pubmed/id/15047131

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006434, umls-concept:C0021665, umls-concept:C0024264, umls-concept:C0205082, umls-concept:C1149301
pubmed:issue	2
pubmed:dateCreated	2004-3-29
pubmed:abstractText	Following severe burn, patients are immunocompromised, making them at increased risk for infection. Exogenous growth hormone has been shown to partially restore immune function. Herein, we investigated Th1/Th2 cytokine profiles and cellular proliferation in isolated mononuclear cells after treatment with exogenous insulin-like growth factor-I (IGF-I), the indirect mediator of many growth hormone effects, in severely burned patients.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01 GM 56687-01, http://linkedlifedata.com/resource/pubmed/grant/T32 GM 08256-09
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0376340
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding..., http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0022-4804
pubmed:author	pubmed-author:HerndonDavid NDN, pubmed-author:KobayashiMakikoM, pubmed-author:RamirezRoque JRJ, pubmed-author:SuzukiFujioF, pubmed-author:WolfSteven ESE, pubmed-author:WoodsideKenneth JKJ
pubmed:issnType	Print
pubmed:volume	117
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	255-61
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:15047131-Adolescent, pubmed-meshheading:15047131-Adult, pubmed-meshheading:15047131-Burns, pubmed-meshheading:15047131-Cell Division, pubmed-meshheading:15047131-Child, pubmed-meshheading:15047131-Child, Preschool, pubmed-meshheading:15047131-Drug Combinations, pubmed-meshheading:15047131-Humans, pubmed-meshheading:15047131-Injections, Intravenous, pubmed-meshheading:15047131-Insulin-Like Growth Factor Binding Protein 3, pubmed-meshheading:15047131-Insulin-Like Growth Factor I, pubmed-meshheading:15047131-Interferon-gamma, pubmed-meshheading:15047131-Interleukin-10, pubmed-meshheading:15047131-Interleukin-2, pubmed-meshheading:15047131-Interleukin-4, pubmed-meshheading:15047131-Lymphocytes, pubmed-meshheading:15047131-Middle Aged, pubmed-meshheading:15047131-Phenotype, pubmed-meshheading:15047131-Recombinant Proteins, pubmed-meshheading:15047131-T-Lymphocytes
pubmed:year	2004
pubmed:articleTitle	Insulin-like growth factor-I/insulin-like growth factor binding protein-3 alters lymphocyte responsiveness following severe burn.
pubmed:affiliation	Shriners Hospitals for Children, 815 Market Street, Galveston, TX 77550-2725, USA. swolf@utmb.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't